How to Help Your Patients Save Money on Zyrtec-D XR: A Provider's Guide to Savings Programs

As an OTC medication, Zyrtec-D XR (cetirizine/pseudoephedrine extended-release) doesn't automatically trigger insurance coverage — but that doesn't mean your patients are stuck paying full retail. With the right guidance at the point of care, you can meaningfully reduce your patients' out-of-pocket costs for this widely used allergy medication.

Understanding the Cost Landscape

Brand-name Zyrtec-D XR retails for approximately $25–$30 per 24-count box. For a patient who takes it twice daily year-round for allergic rhinitis, that's a potential annual cost of $250–$450 at full retail. Generic cetirizine/pseudoephedrine ER significantly reduces this, and discount programs can reduce it further — to as little as $6–$7 per fill.

Key cost benchmarks your patients should know:

Brand Zyrtec-D XR (24-count): $25–$30 average retail

Generic cetirizine/pseudoephedrine ER (24-count): $15–$25 retail; as low as $6.42 with GoodRx

With prescription and insurance coverage: $0–$30 copay on qualifying commercial plans

Strategy 1: Write a Prescription for Cetirizine/Pseudoephedrine ER

Although Zyrtec-D XR is OTC, writing a prescription for cetirizine/pseudoephedrine extended-release is one of the most clinically impactful steps you can take. Benefits:

Insurance coverage potential: Some commercial plans will cover cetirizine/pseudoephedrine ER under Tier 1 or Tier 2 when prescribed. Verify via your e-prescribing platform or direct formulary check.

Pharmacy sourcing: A prescription authorizes the pharmacist to order the drug through their wholesaler when OTC shelf stock is depleted — helping with the access challenges unique to behind-the-counter pseudoephedrine products.

Larger quantity fills: A prescription for a 90-day supply (if covered) typically provides better per-unit cost than buying 24-count boxes OTC.

Strategy 2: Recommend Generic Substitution

Generic cetirizine/pseudoephedrine ER (5mg/120mg) is bioequivalent to brand-name Zyrtec-D XR and available at a significantly lower price. When counseling patients, explicitly tell them that the generic is therapeutically equivalent and recommend using it rather than the brand. Common store brands include Equate (Walmart), GoodSense, KS Aller-Tec D-12, and Wal-Zyr D.

Strategy 3: Direct Patients to GoodRx and Discount Programs

Informing patients about discount card programs at the point of care leads to meaningful savings. GoodRx offers discounts of up to 75% off the average retail price, bringing generic cetirizine/pseudoephedrine ER as low as $6.42. SingleCare provides similar discounts.

A few clinical pearls about these programs:

GoodRx coupons cannot be combined with Medicare Part D — the patient must choose one or the other

GoodRx savings do not count toward insurance deductibles

Prices vary by pharmacy — encourage patients to compare on the GoodRx app before choosing where to fill

Strategy 4: HSA and FSA Eligibility

Cetirizine/pseudoephedrine ER products are eligible for purchase with HSA (Health Savings Account) and FSA (Flexible Spending Account) funds without a prescription. This allows patients to use pre-tax dollars — a meaningful savings for patients in higher tax brackets. Remind patients to use their HSA/FSA debit card when purchasing Zyrtec-D XR or its generics.

Strategy 5: Insurance Formulary Verification

Before assuming a patient's insurance won't cover cetirizine/pseudoephedrine ER, verify via your practice's formulary check tool or encourage the patient to call their plan's member services. Coverage varies significantly by plan, and some commercial plans list cetirizine/pseudoephedrine ER as Tier 1 with minimal copay when prescribed.

Medicare Part D does not cover OTC drugs. Medicaid coverage varies by state — some state programs cover cetirizine/pseudoephedrine with a prescription for Medicaid recipients with documented allergic rhinitis.

Strategy 6: Consider Longer-Term Cost-Effective Alternatives

For patients who need year-round treatment, consider whether a longer-term alternative might provide better value:

Intranasal corticosteroids (INS): Fluticasone (Flonase) is available OTC for ~$15–$20/month, well-covered by insurance, and is the evidence-preferred first-line treatment for allergic rhinitis

Allergen immunotherapy: For patients with significant year-round allergies, subcutaneous or sublingual immunotherapy may be more cost-effective in the long run by reducing the need for daily medications

Patient Assistance Programs

There is no dedicated manufacturer PAP for Zyrtec-D XR. The HealthWell Foundation offers an Urticaria Fund that may assist qualifying patients who take cetirizine for chronic urticaria. Contact: 1-800-675-8416 or healthwellfoundation.org. Federal and state pharmaceutical assistance programs may also be available for low-income patients.

For help helping your patients find Zyrtec-D XR in stock, see

medfinder for providers — a paid service that calls pharmacies near your patient to check which ones have the medication in stock, then texts the results directly to the patient.